Published in Can J Infect Dis Med Microbiol on January 01, 2010
A current perspective on daptomycin for the clinical microbiologist. Clin Microbiol Rev (2013) 1.24
A mutation in the PP2C phosphatase gene in a Staphylococcus aureus USA300 clinical isolate with reduced susceptibility to vancomycin and daptomycin. Antimicrob Agents Chemother (2012) 0.91
Daptomycin-nonsusceptible, vancomycin-intermediate, methicillin-resistant Staphylococcus aureus endocarditis. Can J Infect Dis Med Microbiol (2012) 0.79
Septic Thrombophlebitis with Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia and de Novo Resistance to Vancomycin and Daptomycin. Infect Dis Rep (2017) 0.75
Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol (2000) 34.08
Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol (2003) 14.80
Novel multiplex PCR assay for characterization and concomitant subtyping of staphylococcal cassette chromosome mec types I to V in methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2005) 8.29
Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus. N Engl J Med (2006) 8.20
Staphylococcus aureus endocarditis: a consequence of medical progress. JAMA (2005) 7.41
Tracking the in vivo evolution of multidrug resistance in Staphylococcus aureus by whole-genome sequencing. Proc Natl Acad Sci U S A (2007) 6.14
Infective endocarditis. Lancet (2004) 4.64
Virulent combinations of adhesin and toxin genes in natural populations of Staphylococcus aureus. Infect Immun (2002) 4.62
Genetic changes that correlate with reduced susceptibility to daptomycin in Staphylococcus aureus. Antimicrob Agents Chemother (2006) 4.19
Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother (1990) 4.17
Correlation of daptomycin bactericidal activity and membrane depolarization in Staphylococcus aureus. Antimicrob Agents Chemother (2003) 4.08
The safety and efficacy of daptomycin for the treatment of complicated skin and skin-structure infections. Clin Infect Dis (2004) 4.05
Development of a Canadian standardized protocol for subtyping methicillin-resistant Staphylococcus aureus using pulsed-field gel electrophoresis. J Clin Microbiol (2001) 4.05
Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol (2003) 3.89
Correlation between Reduced Daptomycin Susceptibility and Vancomycin Resistance in Vancomycin-Intermediate Staphylococcus aureus. Antimicrob Agents Chemother (2006) 3.83
Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study. Medicine (Baltimore) (2003) 3.66
Failures in clinical treatment of Staphylococcus aureus Infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother (2007) 3.54
Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother (2000) 3.51
An association between reduced susceptibility to daptomycin and reduced susceptibility to vancomycin in Staphylococcus aureus. Clin Infect Dis (2006) 2.98
Pharmacokinetics and tolerability of daptomycin at doses up to 12 milligrams per kilogram of body weight once daily in healthy volunteers. Antimicrob Agents Chemother (2006) 2.80
Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother (2001) 2.79
Induction of daptomycin heterogeneous susceptibility in Staphylococcus aureus by exposure to vancomycin. Antimicrob Agents Chemother (2006) 2.50
Daptomycin: another novel agent for treating infections due to drug-resistant gram-positive pathogens. Clin Infect Dis (2004) 2.46
Staphylococcus aureus accessory gene regulator (agr) group II: is there a relationship to the development of intermediate-level glycopeptide resistance? J Infect Dis (2003) 2.44
Severe bloodstream infections: a population-based assessment. Crit Care Med (2004) 2.39
Treatment failure resulting from resistance of Staphylococcus aureus to daptomycin. J Clin Microbiol (2006) 2.12
Emergence of a clinical daptomycin-resistant Staphylococcus aureus isolate during treatment of methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis. J Clin Microbiol (2006) 1.88
Novel multiplex PCR assay for detection of the staphylococcal virulence marker Panton-Valentine leukocidin genes and simultaneous discrimination of methicillin-susceptible from -resistant staphylococci. J Clin Microbiol (2006) 1.83
Mechanisms of daptomycin resistance in Staphylococcus aureus. Int J Antimicrob Agents (2006) 1.43
Comparative bactericidal activities of daptomycin and vancomycin against glycopeptide-intermediate Staphylococcus aureus (GISA) and heterogeneous GISA isolates. Antimicrob Agents Chemother (2006) 1.30
Evaluation of endocarditis caused by methicillin-susceptible Staphylococcus aureus developing nonsusceptibility to daptomycin. J Clin Microbiol (2007) 1.28
daptomycin activity against Staphylococcus aureus following vancomycin exposure in an in vitro pharmacodynamic model with simulated endocardial vegetations. Antimicrob Agents Chemother (2007) 1.25
Clinical glycopeptide-intermediate staphylococci tested against arbekacin, daptomycin, and tigecycline. Diagn Microbiol Infect Dis (2004) 1.09
Diminished susceptibility to daptomycin accompanied by clinical failure in a patient with methicillin-resistant Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol (2006) 1.08
Activity of daptomycin against susceptible and multidrug-resistant Gram-positive pathogens collected in the SECURE study (Europe) during 2000-2001. J Antimicrob Chemother (2003) 1.06
In vivo efficacy of linezolid in combination with gentamicin for the treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Int J Antimicrob Agents (2004) 0.92
In vitro and in vivo assessment of linezolid combined with ertapenem: a highly synergistic combination against methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother (2006) 0.82
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 12.74
Methicillin-resistant Staphylococcus aureus in tertiary care institutions on the Canadian prairies 1990-1992. Infect Control Hosp Epidemiol (1994) 3.27
Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell (1992) 2.38
The effect that genotyping errors have on the robustness of common linkage-disequilibrium measures. Am J Hum Genet (2001) 2.29
Effects of divalent cations, protons and calmidazolium at the rat P2X7 receptor. Neuropharmacology (1997) 2.24
Retracted CCR5 blockade in combination with rapamycin prolongs cardiac allograft survival in mice. Clin Exp Immunol (2009) 2.06
Screening and management of renal disease in human immunodeficiency virus-infected patients in Australia. Intern Med J (2013) 2.01
Lipofuscin accumulation, abnormal electrophysiology, and photoreceptor degeneration in mutant ELOVL4 transgenic mice: a model for macular degeneration. Proc Natl Acad Sci U S A (2005) 1.95
Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am J Pathol (1996) 1.92
Engineered doping of organic semiconductors for enhanced thermoelectric efficiency. Nat Mater (2013) 1.89
Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J Med Genet (2004) 1.80
Insulin-like growth factor ligands, receptors, and binding proteins in cancer. J Pathol (2005) 1.73
Evaluation of Roche Amplicor PCR assay for Mycobacterium tuberculosis. J Clin Microbiol (1996) 1.70
The Drosophila spitz gene encodes a putative EGF-like growth factor involved in dorsal-ventral axis formation and neurogenesis. Genes Dev (1992) 1.68
Clinical and genetic studies of an autosomal dominant cone-rod dystrophy with features of Stargardt disease. Ophthalmic Genet (1999) 1.66
HIV infection and AIDS in China, 1985 through 1994. Am J Public Health (1996) 1.64
Bruton's tyrosine kinase links the B cell receptor to nuclear factor kappaB activation. J Exp Med (2000) 1.60
A role for C-C chemokines in fibrotic lung disease. J Leukoc Biol (1995) 1.60
The relationship between human epidermal growth-like factor receptor expression and cellular transformation in NIH3T3 cells. J Biol Chem (1996) 1.58
Diverse macular dystrophy phenotype caused by a novel complex mutation in the ELOVL4 gene. Invest Ophthalmol Vis Sci (2001) 1.58
FZD7 has a critical role in cell proliferation in triple negative breast cancer. Oncogene (2011) 1.53
Protein synthesis requirements for nuclear division, cytokinesis, and cell separation in Saccharomyces cerevisiae. Mol Cell Biol (1991) 1.50
Evidence-based analysis of risk factors for postoperative nausea and vomiting. Br J Anaesth (2012) 1.50
Mutational analysis of a ribonuclease III processing signal. Biochemistry (1993) 1.45
Suppression of src transformation by overexpression of full-length GTPase-activating protein (GAP) or of the GAP C terminus. Mol Cell Biol (1991) 1.44
Iodine supplementation: comparison of oral or intramuscular iodized oil with oral potassium iodide. A controlled trial in Zaire. Int J Epidemiol (1988) 1.44
Human acute myeloid leukemias may be etiologically associated with new human retroviral infection. Leuk Res (1996) 1.43
Functional abnormalities in normally appearing athletes following mild traumatic brain injury: a functional MRI study. Exp Brain Res (2009) 1.42
Ribonuclease III cleavage of a bacteriophage T7 processing signal. Divalent cation specificity, and specific anion effects. Nucleic Acids Res (1993) 1.41
Enhanced human IgE production results from exposure to the aromatic hydrocarbons from diesel exhaust: direct effects on B-cell IgE production. J Allergy Clin Immunol (1995) 1.40
Isolation of multiple mouse cDNAs with coding homology to Saccharomyces cerevisiae CDC25: identification of a region related to Bcr, Vav, Dbl and CDC24. EMBO J (1992) 1.38
A new iterative algorithm to reconstruct the refractive index. Phys Med Biol (2007) 1.36
Anti-biofilm dentin primer with quaternary ammonium and silver nanoparticles. J Dent Res (2012) 1.36
Retroviruses expressing different levels of the normal epidermal growth factor receptor: biological properties and new bioassay. J Cell Biochem (1989) 1.36
Perfect phylogenetic networks with recombination. J Comput Biol (2001) 1.35
Vancomycin-resistant enterococci (VRE) in Canada - Results of the Canadian Nosocomial Infection Surveillance Program 1996 VRE point prevalence surveillance project. Can J Infect Dis (1997) 1.34
Mutations synthetically lethal with cep1 target S. cerevisiae kinetochore components. Genetics (1998) 1.32
Keratinocytes in human wounds express alpha v beta 6 integrin. J Invest Dermatol (1996) 1.32
Endophthalmitis following open globe injury. Br J Ophthalmol (2009) 1.31
Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection. Perit Dial Int (2002) 1.31
Saccharomyces cerevisiae fungemia: case report and review of the literature. Diagn Microbiol Infect Dis (1987) 1.30
Essential protein-protein interactions between Plasmodium falciparum thymidylate synthase and dihydrofolate reductase domains. J Biol Chem (1999) 1.29
Recurrent 17 bp duplication in PITX3 is primarily associated with posterior polar cataract (CPP4). J Med Genet (2004) 1.27
Alteration of brain functional network at rest and in response to YMCA physical stress test in concussed athletes: RsFMRI study. Neuroimage (2011) 1.26
Resting energy expenditure: systematic organization and critique of prediction methods. Obes Res (2001) 1.26
Statistically efficient estimation using population coding. Neural Comput (1998) 1.26
Epidermal growth factor (EGF) promotes human keratinocyte locomotion on collagen by increasing the alpha 2 integrin subunit. Exp Cell Res (1993) 1.24
Lymphocyte blastogenesis and interferon production in adult human leukocyte cultures stimulated with cytomegalovirus antigens. Infect Immun (1980) 1.24
A comparison of the impact of hospital reform on medical subcultures in some Australian and New Zealand hospitals. Aust Health Rev (1999) 1.24
Identification and functional consequences of a new mutation (E155G) in the gene for GCAP1 that causes autosomal dominant cone dystrophy. Am J Hum Genet (2001) 1.23
Probing mechanisms that underlie human neurodegenerative diseases in Drosophila. Annu Rev Genet (2012) 1.21
Evaluation of the leukocyte esterase and nitrite urine dipstick screening tests for detection of bacteriuria in women with suspected uncomplicated urinary tract infections. J Clin Microbiol (1999) 1.20
Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase. Mol Cell Biol (1999) 1.19
Direct detection of verotoxin-producing Escherichia coli in stool samples by PCR. J Clin Microbiol (1995) 1.18
Sequence and S1 nuclease mapping of the 5' region of the dihydrofolate reductase-thymidylate synthase gene of Leishmania major. Nucleic Acids Res (1987) 1.17
A new locus for autosomal dominant stargardt-like disease maps to chromosome 4. Am J Hum Genet (1999) 1.15
Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. Am J Pathol (1993) 1.14
Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. Proc Natl Acad Sci U S A (1985) 1.13
Biochemical characterization of baculovirus-expressed rap1A/Krev-1 and its regulation by GTPase-activating proteins. Mol Cell Biol (1990) 1.13
A blinded comparison of three laboratory protocols for the identification of patients colonized with methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol (2001) 1.13
Conversion of the E1A Cys4 zinc finger to a nonfunctional His2,Cys2 zinc finger by a single point mutation. Proc Natl Acad Sci U S A (1991) 1.13
Utility of zanamivir for chemoprophylaxis of concomitant influenza A and B in a complex continuing care population. Infect Control Hosp Epidemiol (2002) 1.13
Identification of seven serotypes of bluetongue virus from the People's Republic of China. Vet Rec (1999) 1.13
IL-4 plus CD40 monoclonal antibody induces human B cells gamma subclass-specific isotype switch: switching to gamma 1, gamma 3, and gamma 4, but not gamma 2. J Immunol (1995) 1.13
Fetal sensitivity to properties of maternal speech and language. Infant Behav Dev (2008) 1.12
Increased levels of p21ras-GTP and enhanced DNA synthesis accompany elevated tyrosyl phosphorylation of GAP-associated proteins, p190 and p62, in c-src overexpressors. Oncogene (1993) 1.12
Gene array and expression of mouse retina guanylate cyclase activating proteins 1 and 2. Invest Ophthalmol Vis Sci (1998) 1.12
Caenorhabditis elegans as a host model for community-associated methicillin-resistant Staphylococcus aureus. Clin Microbiol Infect (2009) 1.10
Smart nanofibers from combined living radical polymerization, "click chemistry", and electrospinning. ACS Appl Mater Interfaces (2009) 1.10
New method for laboratory detection of AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae. J Clin Microbiol (2004) 1.10
2-[18F]-2-deoxy-D-glucose (FDG) uptake in human tumor cells is related to the expression of GLUT-1 and hexokinase II. Acta Radiol (2008) 1.09
Molecular characterization of the vanD gene cluster and a novel insertion element in a vancomycin-resistant enterococcus isolated in Canada. J Clin Microbiol (2000) 1.08
Integrin receptors and RGD sequences in human keratinocyte migration: unique anti-migratory function of alpha 3 beta 1 epiligrin receptor. J Invest Dermatol (1992) 1.08
A combined procedure to deliver autologous mesenchymal stromal cells to patients with traumatic brain injury. Cytotherapy (2008) 1.07
Proliferation-associated SNF2-like gene (PASG): a SNF2 family member altered in leukemia. Cancer Res (2000) 1.07
Spatially varying properties of the vocal ligament contribute to its eigenfrequency response. J Mech Behav Biomed Mater (2010) 1.07
The role of HLA-DR-DQ haplotypes in variable antibody responses to anthrax vaccine adsorbed. Genes Immun (2011) 1.06
Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats. Brain Res (2009) 1.06
Inhibition of the growth and development of asexual and sexual stages of drug-sensitive and resistant strains of the human malaria parasite Plasmodium falciparum by Neem (Azadirachta indica) fractions. J Ethnopharmacol (1998) 1.06
Lectin-like inhibition of immune complex receptor-mediated stimulation of neutrophils. Effects on cytosolic calcium release and superoxide production. J Immunol (1993) 1.06
Crystal structures of the Streptomyces coelicolor TetR-like protein ActR alone and in complex with actinorhodin or the actinorhodin biosynthetic precursor (S)-DNPA. J Mol Biol (2008) 1.05
Altered K+ current of ventricular myocytes in rats with chronic myocardial infarction. Am J Physiol (1998) 1.04
HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann Neurol (2001) 1.04
Effect of lactic acid isomers on keratinocyte ceramide synthesis, stratum corneum lipid levels and stratum corneum barrier function. Arch Dermatol Res (1996) 1.04
Oncogene-dependent apoptosis in extracts from drug-resistant cells. Genes Dev (1997) 1.03
Molecular epidemiology of vancomycin-resistant enterococcal bacteraemia: results from the Canadian Nosocomial Infection Surveillance Program, 1999-2009. J Antimicrob Chemother (2013) 1.03
Transcription factors Sp1 and Sp3 alter vascular endothelial growth factor receptor expression through a novel recognition sequence. J Biol Chem (1998) 1.03
Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. Intern Med J (2008) 1.02
Antibacterial nanocomposite with calcium phosphate and quaternary ammonium. J Dent Res (2012) 1.02
Vitronectin-driven human keratinocyte locomotion is mediated by the alpha v beta 5 integrin receptor. J Biol Chem (1994) 1.02
Regulation of p21ras activity. Trends Genet (1992) 1.02
Invasive phenotype of Trypanosoma cruzi restricted to a population expressing trans-sialidase. Infect Immun (1996) 1.01
Characterization of human GRK7 as a potential cone opsin kinase. Mol Vis (2001) 1.01
Observation of electron-antineutrino disappearance at Daya Bay. Phys Rev Lett (2012) 1.00
Synthesis and evaluation of furo[3,4-d]pyrimidinones as selective alpha1a-adrenergic receptor antagonists. Bioorg Med Chem Lett (2000) 1.00
Water on the sun. Science (1995) 0.99
Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro. Rheumatology (Oxford) (2004) 0.99
Direct evidence that gamma 1 and gamma 3 switching in human B cells is interleukin-10 dependent. Mol Immunol (1996) 0.99